You are here: Industry Insights > Insulin

News List

Merck Manuals Shares What Parents Need to Know About Adolescent Prediabetes prnewswire
October 30, 2020
Nearly one in five adolescents are living with prediabetes. Prediabetes is a critical warning sign in children at risk of developing type 2 diabetes.
FDA Approves Automated Insulin Delivery, Monitoring System for Young Pediatric Patients americanpharmaceuticalreview
September 02, 2020
The U.S. Food and Drug Administration (FDA) approved the MiniMed 770G System, a hybrid closed loop diabetes management device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses with little or no input ...
Precigen ActoBio Announces Positive Topline Results from Type 1 Diabetes Treatment Study americanpharmaceuticalreview
August 13, 2020
Precigen ActoBio has met the primary endpoint assessing safety and tolerability in the Phase 1b monotherapy portion of the ongoing Phase 1b/2a clinical study investigating AG019 ActoBiotics™ for the treatment of early-onset type 1 diabetes (T1D).
Biocon and Voluntis deal to transform insulin biosimilars personalised care through digital therapeutics: GlobalData expresspharma
July 31, 2020
Biocon plans to create a comprehensive digital therapeutics portfolio by extending its Insulia platform to its complete range of insulin products.
Biocon Biologics and Voluntis collaborate on digital therapeutics for insulins expresspharma
July 22, 2020
Insulia is the first digital therapeutic with regulatory clearance to provide automated titration recommendations for all types of basal insulins.
Companion Medical InPen Receives FDA Clearance for Expanded Pediatric Use americanpharmaceuticalreview
July 02, 2020
Companion Medical, manufacturers of InPen, the only FDA-cleared smart insulin pen system, has announced that they received FDA expanded clearance for all ages to use the InPen System.
FDA Approves Lyumjev americanpharmaceuticalreview
June 29, 2020
The U.S. Food and Drug Administration (FDA) has approved Lyumjev™ (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's new rapid-acting insulin indicated to improve glycemic control in adults with type 1 and ...
Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection expresspharma
June 12, 2020
FDA approval marks a significant milestone to help increase access and affordability of insulin for the millions of Americans living with diabetes-1.
Biocon’s partner Mylan receives favourable ruling from US PTAB on Sanofi’s four device patents for L expresspharma
June 02, 2020
Reportedly, the PTAB also found Sanofi’s proposed amended claims for the ‘486 and ‘844 patents unpatentable.
Novo Nordisk launches social responsibility strategy for diabetes pharmatimes
May 28, 2020
Novo Nordisk has launch a new social responsibility strategy Defeat Diabetes.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page